Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts

scientific article published on 01 May 1991

Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CVR/25.5.391
P953full work available at URLhttp://academic.oup.com/cardiovascres/article-pdf/25/5/391/949311/25-5-391.pdf
P698PubMed publication ID1855244

P2093author name stringP. Braquet
M. Koltai
A. Esanu
A. Tosaki
D. Hosford
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectCardiology and cardiovascular medicineQ96320350
physiologyQ521
P304page(s)391-397
P577publication date1991-05-01
P1433published inCardiovascular ResearchQ4642329
P1476titleEffect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts
P478volume25

Reverse relations

cites work (P2860)
Q52353228Do platelets promote cardiac recovery post myocardial infarction: Roles beyond occlusive ischemic damage.
Q42089750Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits
Q43205546Involvement of A pertussis Toxin Sensitive G-Protein in the Inhibition of Inwardly Rectifying K Currents by Platelet-Activating Factor in Guinea-Pig Atrial Cardiomyocytes
Q79879935Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical
Q41594309Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation?
Q34875121Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury.
Q28609461PAF. A review of its effects, antagonists and possible future clinical implications (Part II)
Q40524595Platelet activating factor antagonists
Q40695898Polymorphonuclear leukocytes in ischemic vascular disease.
Q33933810Reperfusion injury after focal myocardial ischaemia: polymorphonuclear leukocyte activation and its clinical implications

Search more.